Next-generation Bruton tyrosine kinase inhibitors and degraders in the treatment of B-cell malignancies: advances and challenges. [PDF]
Wang Y+5 more
europepmc +1 more source
Case Report: dose adjustment of orelabrutinib for managing central nervous system post-transplant lymphoproliferative disorder following acute lymphoblastic leukemia transplantation. [PDF]
Wang W, Chen J, Guan L.
europepmc +1 more source
X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii [PDF]
Bonagura, V. R.+6 more
core +3 more sources
Case Report: X-linked agammaglobulinemia with progressive neurodegeneration from immunological to neurological implications. [PDF]
Chen X+7 more
europepmc +1 more source
Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children [PDF]
Bitter, Marieke+6 more
core +2 more sources
Effects of Btk-inhibitors with varying selectivity and reversibility on platelet aggregation [PDF]
Duan, Rundan
core
In silico analysis of atrial fibrillation and hypertension mechanism of action secondary to ibrutinib/acalabrutinib in chronic lymphocytic leukemia. [PDF]
Córdoba R+7 more
europepmc +1 more source
‘”Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection [PDF]
David M. Lowe+3 more
core +1 more source